Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 28, 2019 FORM 4 SUBMISSION
4 Jan 28, 2019 FORM 4 SUBMISSION
4 Jan 24, 2019 FORM 4 SUBMISSION
4 Jan 24, 2019 FORM 4 SUBMISSION
4 Jan 24, 2019 FORM 4 SUBMISSION
4 Jan 24, 2019 FORM 4 SUBMISSION
8-K Jan 17, 2019 8-K
8-K Nov 26, 2018 8-K
EFFECT Nov 20, 2018
CORRESP Nov 16, 2018
UPLOAD Nov 15, 2018
8-K Nov 9, 2018 FORM 8-K
424B5 Nov 9, 2018 424B5
S-3 Nov 9, 2018 FORM S-3
S-8 Nov 9, 2018 S-8
10-Q Nov 9, 2018 10-Q
8-K Nov 7, 2018 FORM 8-K
SC 13G/A Aug 10, 2018
10-Q Aug 9, 2018 10-Q
8-K Aug 7, 2018 8-K
8-K Aug 2, 2018 FORM 8-K
SC 13G Jul 9, 2018
4 Jul 2, 2018 4
4 Jun 29, 2018 FORM 4 SUBMISSION
8-K Jun 28, 2018 FORM 8-K
← Newer Page 17 of 28 · 696 filings Older →